Cargando…
Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
Mesenchymal stromal cells (MSCs) have been established as promising candidate sources of universal donor cells for cell therapy due to their contributions to tissue and organ homeostasis, repair, and support by self-renewal and multidifferentiation, as well as by their anti-inflammatory, antiprolife...
Autores principales: | Escacena, Natalia, Quesada-Hernández, Elena, Capilla-Gonzalez, Vivian, Soria, Bernat, Hmadcha, Abdelkrim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530293/ https://www.ncbi.nlm.nih.gov/pubmed/26273307 http://dx.doi.org/10.1155/2015/895714 |
Ejemplares similares
-
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
por: Hmadcha, Abdelkrim, et al.
Publicado: (2020) -
Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity
por: Acosta, Lourdes, et al.
Publicado: (2013) -
Human Mesenchymal Stem Cells Prevent Neurological Complications of Radiotherapy
por: Soria, Bernat, et al.
Publicado: (2019) -
miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation
por: López-Beas, Javier, et al.
Publicado: (2018) -
Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine
por: Capilla-González, Vivian, et al.
Publicado: (2022)